Pulmonary artery catheter market seen reaching $1.58 billion by 2030

The pulmonary artery catheter market is projected to grow from $1.26 billion in 2025 to $1.58 billion by 2030, driven by demand for precise cardiovascular monitoring and rising lung disease cases. North America led the market in 2025, while the report points to stronger use in critical care and high-risk cardiac procedures ahead.

Why it matters: - Pulmonary artery catheters are used to measure pressures in the heart and pulmonary artery, giving clinicians more detailed cardiovascular data in severe heart and lung cases. - The market outlook points to continued demand in critical care, where better hemodynamic monitoring can affect diagnosis and treatment decisions. - Rising lung disease prevalence adds pressure on healthcare systems and supports broader use of pulmonary artery catheters in complex respiratory care.

What happened: - The Business Research Company projected the pulmonary artery catheter market will grow from $1.26 billion in 2025 to $1.32 billion in 2026. - The market is forecast to reach $1.58 billion by 2030, implying a 4.5% compound annual growth rate. - The report was published Aug. 25, 2026, from London. - North America held the largest share of the pulmonary artery catheter market in 2025.

The details: - Historical growth has been driven by more critical care admissions, broader use in cardiac surgeries, improved ICU monitoring, stronger clinician familiarity with pulmonary artery catheters, and a rising burden of cardiovascular disease. - Future growth factors include greater demand for advanced hemodynamic data, more complex ICU cases, continued catheter technology improvements, expansion of critical care infrastructure, and health sector growth in emerging economies. - The report says key trends will include a shift toward minimally invasive hemodynamic monitoring, increased use in high-risk cardiac procedures, growing preference for disposable catheters, improved accuracy and safety, and less routine use in low-risk patients. - Pulmonary artery catheters are commonly used in intensive care settings to monitor cardiac output and pulmonary artery pressure. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. - The 2026 report adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The company offered a free sample report at the sample report. - The full report is available at the full market report. - The company listed LinkedIn at LinkedIn. - The company also listed social profiles at LinkedIn, Facebook, and X.

Between the lines: - The forecast suggests the market is stable rather than explosive, with technology upgrades and case complexity doing more of the work than broad consumer-like adoption. - The report’s note that routine use is falling in low-risk patients points to a more selective, higher-acuity market. - The COPD data from the Centers for Disease Control and Prevention underscores why respiratory disease burden remains a key demand driver.

What's next: - The market is expected to expand gradually through 2030 as critical care needs rise and catheter technology improves. - Adoption may concentrate more in intensive care and high-risk procedures than in routine monitoring. - Emerging economies could add momentum as critical care infrastructure grows.